Evidence map›Paper›PMID 16014958›Full record

ArticleJournal of virology2005

Genetic analysis of the polyomavirus DnaJ domain.

Kerry A Whalen, Rowena de Jesus, Jennifer A Kean, Brian S Schaffhausen

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. The J Domain Proteins ofInternational journal of molecular sciences · 2024
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.Microbiology and molecular biology reviews : MMBR · 2009
    Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kerry A WhalenDepartment of Biochemistry, Tufts University School of Medicine, Boston, MA 02111, USA.
Rowena de Jesus
Jennifer A Kean
Brian S Schaffhausen
Tufts University · US

Funding

PRODUCTS OF THE TRANSFORMING GENES OF POLYOMAVIRUSR01CA034722 · NCI · TUFTS UNIVERSITY BOSTON · PI SCHAFFHAUSEN, BRIAN S · 1985 to 2015
$6.0M
PRODUCTS OF THE TRANSFORMING GENES OF POLYOMA VIRUSR37CA034722 · NCI · TUFTS UNIVERSITY BOSTON · PI SCHAFFHAUSEN, BRIAN S · 1991 to 1998
–
NCI NIH HHS CA34722NCI NIH HHS R01 CA034722
6 · The paper itself

Abstract

Polyomavirus T antigens share a common N-terminal sequence that comprises a DnaJ domain. DnaJ domains activate DnaK molecular chaperones. The functions of J domains have primarily been tested by mutation of their conserved HPD residues. Here, we report detailed mutagenesis of the polyomavirus J domain in both large T (63 mutants) and middle T (51 mutants) backgrounds. As expected, some J mutants were defective in binding DnaK (Hsc70); other mutants retained the ability to bind Hsc70 but were defective in stimulating its ATPase activity. Moreover, the J domain behaves differently in large T and middle T. A given mutation was twice as likely to render large T unstable as it was to affect middle T stability. This apparently arose from middle T's ability to bind stabilizing proteins such as protein phosphatase 2A (PP2A), since introduction of a second mutation preventing PP2A binding rendered some middle T J-domain mutants unstable. In large T, the HPD residues are critical for Rb-dependent effects on the host cell. Residues Q32, A33, Y34, H49, M52, and N56 within helix 2 and helix 3 of the large T J domain were also found to be required for Rb-dependent transactivation. Cyclin A promoter assays showed that J domain function also contributes to large T transactivation that is independent of Rb. Single point mutations in middle T were generally without effect. However, residue Q37 is critical for middle T's ability to form active signaling complexes. The Q37A middle T mutant was defective in association with pp60(c-src) and in transformation.

Indexed as

Adenosine TriphosphatasesAmino Acid SequenceAnimalsAntigens, Viral, TumorDNA Mutational AnalysisHSC70 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHumansMiceModels, MolecularMolecular Sequence DataNIH 3T3 CellsPhosphoprotein PhosphatasesPolyomavirusProtein Phosphatase 2ProteinsAdenosine TriphosphatasesAntigens, Viral, TumorHSC70 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHSPA8 protein, humanHspa8 protein, mousePhosphoprotein PhosphatasesProtein Phosphatase 2ProteinsRBL2 protein, humanRbl2 protein, mouseRetinoblastoma-Like Protein p130

Identifiers

PMID16014958
PMCPMC1181550
OpenAlexW2171259710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.